← Eichor
Condition: Acp3 Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Acp3

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

68Ga-XACP3 PET/CT in Prostate Cancer
NA · 1 location(s) · The First Affiliated Hospital of Xiamen University · NCT07242014Trial of pTVG-HP+Nivo+Targeted Ablation of Resistant Lesions in Non-Castrate RecurrentOMPC
Phase 1 · 1 location(s) · University of Wisconsin, Madison · NCT07090148A Phase I Study to Evaluate the Safety and Dosimetry of Imaging With 68Ga-OncoACP3 in Prostate Cancer
Phase 1 · 2 location(s) · Philogen S.p.A. · NCT07600554Theranostic Applications of Radionuclides in Prostate Cancer
NA · 1 location(s) · Guilin Medical University, China · NCT07559201
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.